Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Peak Bio, Inc.

Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc. Announces Up-listing to OTCQB Market
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting
From Peak Bio, Inc.
Via GlobeNewswire
Tickers PKBO
Peak Bio, Inc. Announces Closing of up to $100 Million Common Stock Purchase Transaction with White Lion Capital
From Peak Bio, Inc.
Via Business Wire
Tickers PKBO
Peak Bio Co., Ltd. to List on NASDAQ Following Successful Business Combination with Ignyte Acquisition Corp.
From Peak Bio, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.